Cambridge Investment Research Advisors’s iShares CMBS ETF CMBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$505K Buy
10,389
+822
+9% +$40K ﹤0.01% 2734
2026
Q1
$466K Buy
9,567
+194
+2% +$9.54K ﹤0.01% 2865
2025
Q4
$460K Buy
+9,373
New +$460K ﹤0.01% 2807
2025
Q3
Sell
-9,852
Closed -$480K 3733
2025
Q2
$480K Buy
+9,852
New +$474K ﹤0.01% 2580
2022
Q1
Sell
-4,073
Closed -$216K 3185
2021
Q4
$216K Buy
+4,073
New +$218K ﹤0.01% 2820
2020
Q2
Sell
-3,894
Closed -$209K 2463
2020
Q1
$209K Sell
3,894
-16,311
-81% -$874K ﹤0.01% 1899
2019
Q4
$1.07M Buy
+20,205
New +$1.07M 0.01% 1110
2016
Q3
Sell
-30,512
Closed -$1.62M 1751
2016
Q2
$1.62M Buy
30,512
+24,115
+377% +$1.26M 0.03% 427
2016
Q1
$333K Buy
+6,397
New +$329K 0.01% 1115

Other funds holding CMBS

Cambridge Investment Research Advisors's CMBS Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its iShares CMBS ETF (CMBS) stake by 8.6% in Q2 2026, buying an estimated $40K and bringing the position to 10,389 shares worth $505K. The position accounts for ﹤0.01% of the portfolio, ranked #2734.

Cambridge Investment Research Advisors first reported a position in CMBS in Q1 2016 and has held it in 9 quarters since. The position peaked at $1.62M in Q2 2016. 19 funds tracked by Wall St. Rank hold CMBS as of Q2 2026.

  • Cambridge Investment Research Advisors held 10,389 shares of iShares CMBS ETF worth $505K as of Q2 2026.
  • Cambridge Investment Research Advisors bought 822 iShares CMBS ETF shares in Q2 2026, an estimated $40K.
  • iShares CMBS ETF made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #2734 holding.
  • Cambridge Investment Research Advisors first reported a position in iShares CMBS ETF in Q1 2016 and has held it in 9 quarters since.
  • Cambridge Investment Research Advisors's iShares CMBS ETF position peaked at $1.62M in Q2 2016.
  • 19 funds tracked by Wall St. Rank held iShares CMBS ETF as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.